← Leaderboards
Catherine Orrell
New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
$5,255,737
Attributed
$11,569,702
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,569,702 · 6
By mechanism
R01$10,648,117 · 4
R34$617,179 · 1
R21$304,406 · 1
Top collaborators
- Lora L Sabin9 shared
- Monica Gandhi5 shared
- Robert H Remien5 shared
- Gert Uves Van Zyl5 shared
- Ingrid T. Katz3 shared
- Sheree Renae Schwartz3 shared
- Eric Hermann Decloedt2 shared
Most similar at New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
Same institution · by research overlap
- Elias Dakwar$9,906,648
Others in their field
Top investigators on “South Africa”
- Myron S Cohen · Family Health International$328,906,964
- Wafaa M. El-Sadr · Columbia University Health Sciences$308,491,923
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$167,971,708
- Carol Nesel · Westat$157,229,158
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$129,836,128
- David R. Weir · University Of Michigan At Ann Arbor$111,063,207
Research focus
South AfricaAntiretroviral TherapyAdherenceParticipantViralPharmacy FacilityTreatment AdherenceCaringViral Load ResultDesignSuccessInnovationFollow-UpClinicCompliance BehaviorMonitorProviderFutureSamplingTechnologySouth AfricanSecondary OutcomeHigh RiskInterview
Grant awards (24)
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$449,181
R01 · FY2025 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$392,957
R01 · FY2025 · MH
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$260,740
R01 · FY2025 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$159,336
R01 · FY2025 · MH
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$780,447
R01 · FY2024 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$534,950
R01 · FY2024 · MH
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$326,142
R01 · FY2024 · AI
Designing Next Generation Treatment Strategies for Adolescents and Young Adults Living with HIV (The NextGen Study)$210,761
R34 · FY2024 · MH
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke$138,481
R21 · FY2024 · TW
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$532,562
R01 · FY2023 · MH
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$331,897
R01 · FY2023 · AI
Designing Next Generation Treatment Strategies for Adolescents and Young Adults Living with HIV (The NextGen Study)$224,364
R34 · FY2023 · MH
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke$165,925
R21 · FY2023 · TW
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$560,193
R01 · FY2022 · MH
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$338,904
R01 · FY2022 · AI
Designing Next Generation Treatment Strategies for Adolescents and Young Adults Living with HIV (The NextGen Study)$182,054
R34 · FY2022 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$687,050
R01 · FY2021 · MH
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$343,910
R01 · FY2021 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa$749,372
R01 · FY2020 · AI
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$343,464
R01 · FY2020 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa$865,505
R01 · FY2019 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa$1,099,420
R01 · FY2018 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa$1,077,794
R01 · FY2017 · AI
Use of ARV Drug Levels in DBS to Assess and Manage ART Adherence in South Africa$814,293
R01 · FY2016 · AI